From: support@bartonpublishing.com
Subject: Harvard Medical Students Rebel Against Big Pharma's Influence In The Classroom
Date: March 9, 2010 5:28:38 AM CST
To: shannonnelson@tds.net
Reply-To: support@bartonpublishing.com
Dear Friend,
200 Harvard Medical School STUDENTS are confronting the
administration demanding an end to pharmaceutical industry
influence in the classroom.
A front page report in the Business section of the New York
Times should bestir some of Harvard Medical School alumni. 200
Harvard Medical School STUDENTS are confronting the
administration demanding an end to pharmaceutical industry
influence in the classroom.
"The students say they worry that pharmaceutical industry
scandals in recent years – including some criminal convictions,
billions of dollars in fines, proof of bias in research and
publishing and false marketing claims – have cast a bad light
on the medical profession. And they criticize Harvard as being
less vigilant than other leading medical schools in monitoring
potential financial conflicts by faculty members."
Harvard received the lowest grade–an F--from the American
Medical Student Association, a national group that rates how well
medical schools monitor and control drug industry money. Harvard
Medical School’s peers received much higher grades, ranging
from the A for the University of Pennsylvania, to B’s received
by Stanford, Columbia and New York University, to the C for Yale.
The revolt began when a first year medical student "grew wary"
when a professor promoted cholesterol drugs and "seemed to
belittle a student who asked about side effects." He later
discovered that the professor, a full-time Harvard Medical
faculty member, was a paid consultant to 10 drug industry
companies, including manufacturers of cholesterol drugs.
Another first year student said:
"Before coming here, I had no idea how much influence 'big
pharm.' companies had on medical education. And it’s something
that’s purposely meant to be under the table, providing
information under the guise of education when that information is
also presented for marketing purposes."
The fact is, no one is keeping track of faculty income from
industry, or covert marketing pitches infiltrating the classroom:
"The school said it was unable to provide annual measures of the
money flow to its faculty.." One Harvard professor’s
disclosure in class listed 47 company affiliations.
Read more about Medical Schools and ties to Big Pharma
http://www.bartonpublishing.com/blog/ha ... arma-ties/
Yours for excellent health,
Joe Barton
Founder & CEO
Barton Publishing Inc.
Harvard students vs. Pharma in classrooms
-
Shannon Nelson
- Posts: 8848
- Joined: Fri Jun 28, 2002 10:00 pm
Re: Harvard students vs. Pharma in classrooms
Over the years I’ve taken a number of courses/seminars at Harvard Medical and have found that most of the med school students were very well aware of where the information was coming from (big pharma, professors well paid by big pharma and research grants funded by big pharma). It seems a majority had already been indoctrinated that pharma was the ‘best’ source of information – even before they were very far along in med school. Certainly they highly reverenced the ‘scientific’ study and documentation that went into pharma products. Over time I have seen a few more embrace the idea that ‘integrative’ medicine was not a total evil – but that has been very slow in coming – even though Harvard has a very active ‘integrative’ medicine group.
Those students I spoke with that were concerned about pharma influence felt they had to keep it quiet if they wanted to show their professors they were ‘serious’, pass their courses and get out with a degree and recommendations. I hope that feeling is changing – sounds like a few brave souls are willing to confront the administration now. Interesting that it is fear of litigation that is fueling this student uprising.
Donna
D C Rona, PhD, ND, DHM
www.HomeopathOnTheWeb.com
From: minutus@yahoogroups.com [mailto:minutus@yahoogroups.com] On Behalf Of Shannon Nelson
Sent: Tuesday, March 09, 2010 7:54 AM
To: minutus@yahoogroups.com
Subject: [Minutus] Harvard students vs. Pharma in classrooms
From: support@bartonpublishing.com
Subject: Harvard Medical Students Rebel Against Big Pharma's Influence In The Classroom
Date: March 9, 2010 5:28:38 AM CST
To: shannonnelson@tds.net
Reply-To: support@bartonpublishing.com
Dear Friend,
200 Harvard Medical School STUDENTS are confronting the
administration demanding an end to pharmaceutical industry
influence in the classroom.
A front page report in the Business section of the New York
Times should bestir some of Harvard Medical School alumni. 200
Harvard Medical School STUDENTS are confronting the
administration demanding an end to pharmaceutical industry
influence in the classroom.
"The students say they worry that pharmaceutical industry
scandals in recent years – including some criminal convictions,
billions of dollars in fines, proof of bias in research and
publishing and false marketing claims – have cast a bad light
on the medical profession. And they criticize Harvard as being
less vigilant than other leading medical schools in monitoring
potential financial conflicts by faculty members."
Harvard received the lowest grade–an F--from the American
Medical Student Association, a national group that rates how well
medical schools monitor and control drug industry money. Harvard
Medical School’s peers received much higher grades, ranging
from the A for the University of Pennsylvania, to B’s received
by Stanford, Columbia and New York University, to the C for Yale.
The revolt began when a first year medical student "grew wary"
when a professor promoted cholesterol drugs and "seemed to
belittle a student who asked about side effects." He later
discovered that the professor, a full-time Harvard Medical
faculty member, was a paid consultant to 10 drug industry
companies, including manufacturers of cholesterol drugs.
Another first year student said:
"Before coming here, I had no idea how much influence 'big
pharm.' companies had on medical education. And it’s something
that’s purposely meant to be under the table, providing
information under the guise of education when that information is
also presented for marketing purposes."
The fact is, no one is keeping track of faculty income from
industry, or covert marketing pitches infiltrating the classroom:
"The school said it was unable to provide annual measures of the
money flow to its faculty.." One Harvard professor’s
disclosure in class listed 47 company affiliations.
Read more about Medical Schools and ties to Big Pharma
http://www.bartonpublishing.com/blog/ha ... arma-ties/
Yours for excellent health,
Joe Barton
Founder & CEO
Barton Publishing Inc.
Those students I spoke with that were concerned about pharma influence felt they had to keep it quiet if they wanted to show their professors they were ‘serious’, pass their courses and get out with a degree and recommendations. I hope that feeling is changing – sounds like a few brave souls are willing to confront the administration now. Interesting that it is fear of litigation that is fueling this student uprising.
Donna
D C Rona, PhD, ND, DHM
www.HomeopathOnTheWeb.com
From: minutus@yahoogroups.com [mailto:minutus@yahoogroups.com] On Behalf Of Shannon Nelson
Sent: Tuesday, March 09, 2010 7:54 AM
To: minutus@yahoogroups.com
Subject: [Minutus] Harvard students vs. Pharma in classrooms
From: support@bartonpublishing.com
Subject: Harvard Medical Students Rebel Against Big Pharma's Influence In The Classroom
Date: March 9, 2010 5:28:38 AM CST
To: shannonnelson@tds.net
Reply-To: support@bartonpublishing.com
Dear Friend,
200 Harvard Medical School STUDENTS are confronting the
administration demanding an end to pharmaceutical industry
influence in the classroom.
A front page report in the Business section of the New York
Times should bestir some of Harvard Medical School alumni. 200
Harvard Medical School STUDENTS are confronting the
administration demanding an end to pharmaceutical industry
influence in the classroom.
"The students say they worry that pharmaceutical industry
scandals in recent years – including some criminal convictions,
billions of dollars in fines, proof of bias in research and
publishing and false marketing claims – have cast a bad light
on the medical profession. And they criticize Harvard as being
less vigilant than other leading medical schools in monitoring
potential financial conflicts by faculty members."
Harvard received the lowest grade–an F--from the American
Medical Student Association, a national group that rates how well
medical schools monitor and control drug industry money. Harvard
Medical School’s peers received much higher grades, ranging
from the A for the University of Pennsylvania, to B’s received
by Stanford, Columbia and New York University, to the C for Yale.
The revolt began when a first year medical student "grew wary"
when a professor promoted cholesterol drugs and "seemed to
belittle a student who asked about side effects." He later
discovered that the professor, a full-time Harvard Medical
faculty member, was a paid consultant to 10 drug industry
companies, including manufacturers of cholesterol drugs.
Another first year student said:
"Before coming here, I had no idea how much influence 'big
pharm.' companies had on medical education. And it’s something
that’s purposely meant to be under the table, providing
information under the guise of education when that information is
also presented for marketing purposes."
The fact is, no one is keeping track of faculty income from
industry, or covert marketing pitches infiltrating the classroom:
"The school said it was unable to provide annual measures of the
money flow to its faculty.." One Harvard professor’s
disclosure in class listed 47 company affiliations.
Read more about Medical Schools and ties to Big Pharma
http://www.bartonpublishing.com/blog/ha ... arma-ties/
Yours for excellent health,
Joe Barton
Founder & CEO
Barton Publishing Inc.
-
Teresa Kramer
- Posts: 287
- Joined: Wed Apr 01, 2020 10:00 pm
Re: Harvard students vs. Pharma in classrooms
There is a very nice little story by Dr. Tim Dooley (of Beyond Flat Earth Medicine fame) in Homeopathy Today about when he was a young med student and was given a stethoscope, a nice one, by a pharmaceutical company. He used it for a bit, but felt worse and worse about taking it from that source and finally got rid of it. That whole article, I believe is about bigPharma’s influence on conventional doctors. [He was one until he became a homeopath.] Teresa (Northern VA)
________________________________
From: minutus@yahoogroups.com [mailto:minutus@yahoogroups.com] On Behalf Of Rona
Sent: Tuesday, March 09, 2010 10:19 AM
To: minutus@yahoogroups.com
Subject: RE: [Minutus] Harvard students vs. Pharma in classrooms
Over the years I’ve taken a number of courses/seminars at Harvard Medical and have found that most of the med school students were very well aware of where the information was coming from (big pharma, professors well paid by big pharma and research grants funded by big pharma). It seems a majority had already been indoctrinated that pharma was the ‘best’ source of information – even before they were very far along in med school. Certainly they highly reverenced the ‘scientific’ study and documentation that went into pharma products. Over time I have seen a few more embrace the idea that ‘integrative’ medicine was not a total evil – but that has been very slow in coming – even though Harvard has a very active ‘integrative’ medicine group.
Those students I spoke with that were concerned about pharma influence felt they had to keep it quiet if they wanted to show their professors they were ‘serious’, pass their courses and get out with a degree and recommendations. I hope that feeling is changing – sounds like a few brave souls are willing to confront the administration now. Interesting that it is fear of litigation that is fueling this student uprising.
Donna
D C Rona, PhD, ND, DHM
www.HomeopathOnTheWeb.com
From: minutus@yahoogroups.com [mailto:minutus@yahoogroups.com] On Behalf Of Shannon Nelson
Sent: Tuesday, March 09, 2010 7:54 AM
To: minutus@yahoogroups.com
Subject: [Minutus] Harvard students vs. Pharma in classrooms
From: support@bartonpublishing.com
Subject: Harvard Medical Students Rebel Against Big Pharma's Influence In The Classroom
Date: March 9, 2010 5:28:38 AM CST
To: shannonnelson@tds.net
Reply-To: support@bartonpublishing.com
Dear Friend,
200 Harvard Medical School STUDENTS are confronting the
administration demanding an end to pharmaceutical industry
influence in the classroom.
A front page report in the Business section of the New York
Times should bestir some of Harvard Medical School alumni. 200
Harvard Medical School STUDENTS are confronting the
administration demanding an end to pharmaceutical industry
influence in the classroom.
"The students say they worry that pharmaceutical industry
scandals in recent years – including some criminal convictions,
billions of dollars in fines, proof of bias in research and
publishing and false marketing claims – have cast a bad light
on the medical profession. And they criticize Harvard as being
less vigilant than other leading medical schools in monitoring
potential financial conflicts by faculty members."
Harvard received the lowest grade–an F--from the American
Medical Student Association, a national group that rates how well
medical schools monitor and control drug industry money. Harvard
Medical School’s peers received much higher grades, ranging
from the A for the University of Pennsylvania, to B’s received
by Stanford, Columbia and New York University, to the C for Yale.
The revolt began when a first year medical student "grew wary"
when a professor promoted cholesterol drugs and "seemed to
belittle a student who asked about side effects." He later
discovered that the professor, a full-time Harvard Medical
faculty member, was a paid consultant to 10 drug industry
companies, including manufacturers of cholesterol drugs.
Another first year student said:
"Before coming here, I had no idea how much influence 'big
pharm.' companies had on medical education. And it’s something
that’s purposely meant to be under the table, providing
information under the guise of education when that information is
also presented for marketing purposes."
The fact is, no one is keeping track of faculty income from
industry, or covert marketing pitches infiltrating the classroom:
"The school said it was unable to provide annual measures of the
money flow to its faculty.." One Harvard professor’s
disclosure in class listed 47 company affiliations.
Read more about Medical Schools and ties to Big Pharma
http://www.bartonpublishing.com/blog/ha ... arma-ties/
Yours for excellent health,
Joe Barton
Founder & CEO
Barton Publishing Inc.
________________________________
From: minutus@yahoogroups.com [mailto:minutus@yahoogroups.com] On Behalf Of Rona
Sent: Tuesday, March 09, 2010 10:19 AM
To: minutus@yahoogroups.com
Subject: RE: [Minutus] Harvard students vs. Pharma in classrooms
Over the years I’ve taken a number of courses/seminars at Harvard Medical and have found that most of the med school students were very well aware of where the information was coming from (big pharma, professors well paid by big pharma and research grants funded by big pharma). It seems a majority had already been indoctrinated that pharma was the ‘best’ source of information – even before they were very far along in med school. Certainly they highly reverenced the ‘scientific’ study and documentation that went into pharma products. Over time I have seen a few more embrace the idea that ‘integrative’ medicine was not a total evil – but that has been very slow in coming – even though Harvard has a very active ‘integrative’ medicine group.
Those students I spoke with that were concerned about pharma influence felt they had to keep it quiet if they wanted to show their professors they were ‘serious’, pass their courses and get out with a degree and recommendations. I hope that feeling is changing – sounds like a few brave souls are willing to confront the administration now. Interesting that it is fear of litigation that is fueling this student uprising.
Donna
D C Rona, PhD, ND, DHM
www.HomeopathOnTheWeb.com
From: minutus@yahoogroups.com [mailto:minutus@yahoogroups.com] On Behalf Of Shannon Nelson
Sent: Tuesday, March 09, 2010 7:54 AM
To: minutus@yahoogroups.com
Subject: [Minutus] Harvard students vs. Pharma in classrooms
From: support@bartonpublishing.com
Subject: Harvard Medical Students Rebel Against Big Pharma's Influence In The Classroom
Date: March 9, 2010 5:28:38 AM CST
To: shannonnelson@tds.net
Reply-To: support@bartonpublishing.com
Dear Friend,
200 Harvard Medical School STUDENTS are confronting the
administration demanding an end to pharmaceutical industry
influence in the classroom.
A front page report in the Business section of the New York
Times should bestir some of Harvard Medical School alumni. 200
Harvard Medical School STUDENTS are confronting the
administration demanding an end to pharmaceutical industry
influence in the classroom.
"The students say they worry that pharmaceutical industry
scandals in recent years – including some criminal convictions,
billions of dollars in fines, proof of bias in research and
publishing and false marketing claims – have cast a bad light
on the medical profession. And they criticize Harvard as being
less vigilant than other leading medical schools in monitoring
potential financial conflicts by faculty members."
Harvard received the lowest grade–an F--from the American
Medical Student Association, a national group that rates how well
medical schools monitor and control drug industry money. Harvard
Medical School’s peers received much higher grades, ranging
from the A for the University of Pennsylvania, to B’s received
by Stanford, Columbia and New York University, to the C for Yale.
The revolt began when a first year medical student "grew wary"
when a professor promoted cholesterol drugs and "seemed to
belittle a student who asked about side effects." He later
discovered that the professor, a full-time Harvard Medical
faculty member, was a paid consultant to 10 drug industry
companies, including manufacturers of cholesterol drugs.
Another first year student said:
"Before coming here, I had no idea how much influence 'big
pharm.' companies had on medical education. And it’s something
that’s purposely meant to be under the table, providing
information under the guise of education when that information is
also presented for marketing purposes."
The fact is, no one is keeping track of faculty income from
industry, or covert marketing pitches infiltrating the classroom:
"The school said it was unable to provide annual measures of the
money flow to its faculty.." One Harvard professor’s
disclosure in class listed 47 company affiliations.
Read more about Medical Schools and ties to Big Pharma
http://www.bartonpublishing.com/blog/ha ... arma-ties/
Yours for excellent health,
Joe Barton
Founder & CEO
Barton Publishing Inc.
-
Bill Giman
- Posts: 166
- Joined: Thu Jul 15, 2004 10:00 pm
Re: Harvard students vs. Pharma in classrooms
Big Pharma has a great influence in the classroom from the beginning of a person's "medical" education.
About 5 years ago, I took a course on Anatomy & Phys 101/102 (beginners course) at a local community college. Most of my classmates were in their first or second year.
The book used for this course was filled with "brand name" drug applications for conditions or problems written in this book about Anatomy & Phys 101, e.g., use this medication for hair loss.
Obviously the writer of this book was paid handsomely by Pharma to write about their products.
I was extremely angered by these references in an Anatomy & Phys book.
I wanted to go to the Dean to talk about this, but never did.
So the indoctrination starts very early in person's medical education by Big Pharma, and never ends.
Bill Giman
____________________________________________________________
Nutrition
Improve your career health. Click now to study nutrition!
http://thirdpartyoffers.juno.com/TGL214 ... ASQwAAAAA=
About 5 years ago, I took a course on Anatomy & Phys 101/102 (beginners course) at a local community college. Most of my classmates were in their first or second year.
The book used for this course was filled with "brand name" drug applications for conditions or problems written in this book about Anatomy & Phys 101, e.g., use this medication for hair loss.
Obviously the writer of this book was paid handsomely by Pharma to write about their products.
I was extremely angered by these references in an Anatomy & Phys book.
I wanted to go to the Dean to talk about this, but never did.
So the indoctrination starts very early in person's medical education by Big Pharma, and never ends.
Bill Giman
____________________________________________________________
Nutrition
Improve your career health. Click now to study nutrition!
http://thirdpartyoffers.juno.com/TGL214 ... ASQwAAAAA=